Anzeige
++++++ Was, wenn die alten Minen erst der Anfang waren?: Rio Grandes hochgradige Gold-Silber-Spur wird immer größer ++++++
Portfolio Tracker
Alle Depots an einem Ort. Dein Gesamtvermögen immer im Blick, tiefgründige Renditeanalysen und Dividendenplaner.
Anzeige
AUXLY CANNABIS Forum: Community User: JanPreuss
Kommentare 15.244
A
Antenne_4.0,
17.05.2018 14:13 Uhr
0
Verstehe den Inhalt nicht zu 100%.
Kann das kurz jemand in 3 Sätzen erklären?
J
Jorginho1975,
17.05.2018 14:09 Uhr
0
Nicht schlecht....
S
Syntax,
17.05.2018 14:02 Uhr
0
Läuft
J
Jorginho1975,
17.05.2018 13:56 Uhr
0
Cannabis Wheaton Announces Closing of Dosecann Acquisition
V.CBW | 23 minutes ago
VANCOUVER, British Columbia, May 17, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX-V:CBW) ("Cannabis Wheaton" or the "Company") is pleased to announce that it has closed its previously announced acquisition (the “Transaction”) of all of the outstanding securities of Dosecann Inc. (“Dosecann”), a late-stage “Licensed Dealer” applicant pursuant to the Narcotic Control Regulations (the “NCR”).
Located in the biotech hub of Charlottetown, Prince Edward Island, Dosecann is currently completing the buildout of a 42,000 square foot facility, purpose-built for the research, development, extraction, formulation, filling and packaging of cannabis-based products. Upon receipt of regulatory approval, Dosecann will leverage its state-of-the-art facility to begin developing a range of value added cannabis-based products for the Company and its streaming partners to ultimately be sold to medical cannabis patients and, upon approval, into the natural health product and adult-use cannabis markets.
Pursuant to the acquisition agreement dated April 3, 2018, the Company has acquired all of the outstanding securities of Dosecann (the “Dosecann Securities”) by way of a “three-cornered amalgamation” (the “Acquisition”) for an aggregate purchase price of up to $38,000,000, payable in common shares of the Company to the holders of the Dosecann Securities (the “Consideration Shares”), subject to the satisfaction of certain post-closing time and performance-based milestones. As part of the Acquisition, all outstanding convertible securities of Dosecann have either been converted into Dosecann common shares and exchanged for Consideration Shares or have otherwise been exchanged for convertible securities of Cannabis Wheaton based on the exchange ratio used in the Acquisition.
The Company has issued 24,494,496 Consideration Shares at a deemed price of $1.47, of which 9,630,947 are subject to performance based milestone release. In addition, the Company has assumed the obligations of the existing Dosecann common share purchase warrants, resulting in the issuance of 5,071,248 common share purchase warrants in the capital of the Company (the “Replacement Warrants”). Each whole Replacement Warrant entitles the holder to purchase one common share of the Company at an exercise price of $0.962 until January 2020. As a result of the closing of the Transaction, Dosecann is now a wholly-owned subsidiary of the Company.
Upon receipt of a Dealer’s Licence pursuant to the NCR, Dosecann will serve a critical role in the “mid-stream” segment of Cannabis Wheaton’s platform. Dosecann will be the Company’s primary facility for various value enhancing intellectual property related activities such as extraction, processing, branding and licensing, product development and manufacturing, research and development, and various international opportunities. The Company also intends to utilize the Dosecann facility for the commercialization of various cannabis products available under the Company’s recently announced license agreement with Dixie Brands, Inc., as permitted by applicable law.
Hugo Alves, President and Director of Cannabis Wheaton stated, “The addition of Dosecann to the Cannabis Wheaton platform provides us with a strategic regulatory tool that we believe will be increasingly important under the proposed Cannabis Act. We couldn’t be more excited to be working with the high caliber team Greg Boone has put together to develop Dosecann into a true ‘center of excellence’ in the creation of intellectual property, product development and commercialization. We believe the Dosecann team’s proven ability to take pharmaceutical, natural health products, and consumer packaged goods from conceptualization to commercialization will be of huge value to the Company’s wholly owned subsidiaries and streaming partners as we enter the next leg of growth in the domestic and international markets for cannabis products.”
Greg Boone, Founder and CEO of Dosecann commented, “The Dosecann team is delighted to partner with Cannabis Wheaton as we near the completion and licensing of our purpose-built facility. Given their in-depth industry knowledge and exceptionally strong management team, we believe Cannabis Wheaton is the perfect partner to bring Dosecann’s unique product formulations to market. We look forward to collaborating with Hugo and his team going forward.”
Dr. Christina Woollard, Dosecann’s Chief Science Officer states, “I joined Dosecann because I was confident that Dosecann would play a significant role in the Canadian cannabis industry. I have dedicated my career to the study and commercialization of patient focused medicines and I look forward to leveraging my 18 years of experience as the Head of Pharmaceutical Development for GW Pharmaceuticals to help Dosecann become the benchmark cannabis manufacturing and development facility in Canada.”
rr12,
17.05.2018 8:48 Uhr
0
den haschis ist manchmal nicht zu trauen:))))))))))))))
rr12,
17.05.2018 8:48 Uhr
0
ja hoffentlich nicht zum traden
GonorrhöeGisela,
17.05.2018 8:18 Uhr
0
Die Jungs decken sich auch gut ein :)
S
Syntax,
17.05.2018 7:31 Uhr
0
Insiderkäufe
09.05.2018 Jeffrey Tung +3.833.332
20.04.2018 Hugo Alves +1.000.000
20.04.2018 Jeffrey Tung +333.333
N
Niko2411,
16.05.2018 18:45 Uhr
0
IRW-News: Marapharm Ventures Inc.: Marapharm Ventures Inc. Erstes Cannabis-Reformgesetz in der Geschichte der USA - http://www.boersennews.de/nachrichten/artikel/irw-news-marapharm-ventures-inc-marapharm-ventures-inc-erstes-cannabis-reformgesetz-in-der-geschichte-der-usa/692028461
Logiii,
16.05.2018 18:20 Uhr
0
Kla 100%tig , eventuell etwas später ,aber die kommt .
a
anbaee_,
16.05.2018 18:15 Uhr
0
Legalisierung wird definitiv kommen. Meine Meinung.
S
Syntax,
16.05.2018 17:58 Uhr
0
Mag sein aber langfristig nicht weil der medizinischer Sektor nicht betroffen ist und CW ist hier stark aufgestellt.
M
Mr_Digi,
16.05.2018 17:37 Uhr
0
@Syntax: darauf spekulier ich auch. Hoffentlich verkacken es die Canadischen Politiker nicht, sonst Ciao Kurs
S
Syntax,
16.05.2018 17:02 Uhr
0
so langsam sollten die Kurse anziehen ...nur noch 3 Wochen bis zum 07.06
F
FC_Hollywood,
16.05.2018 16:49 Uhr
0
Oder ein tolles Hoch nach den letzten Wochen/Monaten ;)
GonorrhöeGisela,
16.05.2018 16:34 Uhr
0
Die 1,10€ sind ne kleine Hürde. :)
Mehr zu diesem Wert
|
|
Thema | ||
|---|---|---|---|
| 1 | AUXLY CANNABIS Hauptdiskussion | ||
| 2 | Auxly Investoren Gruppe (18+) |
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | VONOVIA Hauptdiskussion | -2,33 % | |
| 2 | DAX Prognose / Germany 40 | -1,00 % | |
| 3 | DAX / Germany 40 Hauptdiskussion | -1,00 % | |
| 4 | ATOS Hauptdiskussion | -2,85 % | |
| 5 | SAP Hauptdiskussion | -2,52 % | |
| 6 | BioNTech Hauptdiskussion | -0,58 % | |
| 7 | Novo Nordisk nach Split | -0,81 % | |
| 8 | EVOTEC Hauptdiskussion | -2,48 % | |
| 9 | ORACLE Hauptdiskussion | -1,09 % | |
| 10 | Goldpreis Hauptdiskussion | -0,65 % | Alle Diskussionen |
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | VONOVIA Hauptdiskussion | -2,33 % | |
| 2 | ATOS Hauptdiskussion | -2,85 % | |
| 3 | SAP Hauptdiskussion | -2,58 % | |
| 4 | BioNTech Hauptdiskussion | -0,58 % | |
| 5 | Novo Nordisk nach Split | -0,81 % | |
| 6 | EVOTEC Hauptdiskussion | -2,48 % | |
| 7 | ORACLE Hauptdiskussion | -1,09 % | |
| 8 | NEL ASA Hauptdiskussion | -1,59 % | |
| 9 | INFINEON Hauptdiskussion | -0,76 % | |
| 10 | Renk und alles was dazugehört | -0,58 % | Alle Diskussionen |